首页> 外文期刊>Nature Genetics >Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass
【24h】

Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass

机译:综合基因组学方法牵涉骨糖蛋白(Ogn)调节左心室质量

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Left ventricular mass ( LVM) and cardiac gene expression are complex traits regulated by factors both intrinsic and extrinsic to the heart. To dissect the major determinants of LVM, we combined expression quantitative trait locus(1) and quantitative trait transcript(2) ( QTT) analyses of the cardiac transcriptome in the rat. Using these methods and in vitro functional assays, we identified osteoglycin ( Ogn) as a major candidate regulator of rat LVM, with increased Ogn protein expression associated with elevated LVM. We also applied genome-wide QTT analysis to the human heart and observed that, out of similar to 22,000 transcripts, OGN transcript abundance had the highest correlation with LVM. We further confirmed a role for Ogn in the in vivo regulation of LVM in Ogn knockout mice. Taken together, these data implicate Ogn as a key regulator of LVM in rats, mice and humans, and suggest that Ogn modifies the hypertrophic response to extrinsic factors such as hypertension and aortic stenosis.
机译:左心室质量(LVM)和心脏基因表达是复杂的性状,受心脏内在和外在因素调节。为了剖析LVM的主要决定因素,我们结合了大鼠心脏转录组的表达定量性状基因座(1)和定量性状转录本(2)(QTT)分析。使用这些方法和体外功能测定,我们确定骨蛋白(Ogn)是大鼠LVM的主要候选调节物,与LVM升高相关的Ogn蛋白表达增加。我们还对人类心脏进行了全基因组QTT分析,发现与22,000个转录本相似,OGN转录本丰度与LVM的相关性最高。我们进一步证实了Ogn在Ogn基因敲除小鼠体内对LVM的体内调节中的作用。综上所述,这些数据暗示Ogn是大鼠,小鼠和人类中LVM的关键调节剂,并表明Ogn修饰了对外部因素(例如高血压和主动脉狭窄)的肥大反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号